Douglas J. Gentilcore

Insider Reports History

Entity
Individual
Location
C/O Y Mabs Therapeutics, Inc., 230 Park Avenue, Suite 3350, New York, NY
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas J. Gentilcore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Y-mAbs Therapeutics, Inc. SVP, Danyelza Bus. Unit Head Employee Stock Option (right to buy) 143K Jan 17, 2025 Direct

Insider Reports Filed by Douglas J. Gentilcore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
YMAB Y-mAbs Therapeutics, Inc. Jan 17, 2025 1 $0 4 Jan 22, 2025 SVP, Danyelza Bus. Unit Head
YMAB Y-mAbs Therapeutics, Inc. Jan 7, 2025 0 $0 3 Jan 17, 2025 SVP, Danyelza Bus. Unit Head